Business Description
Arrowhead Pharmaceuticals Inc
NAICS : 541714
SIC : 2834
ISIN : US04280A1007
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.68 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -0.99 | |||||
Beneish M-Score | -7.62 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 37.2 | |||||
3-Year EBITDA Growth Rate | -23.9 | |||||
3-Year EPS without NRI Growth Rate | -31.7 | |||||
3-Year FCF Growth Rate | -42.5 | |||||
3-Year Book Growth Rate | -17.5 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.65 | |||||
Quick Ratio | 4.65 | |||||
Cash Ratio | 4.49 | |||||
Days Sales Outstanding | 656.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | -1.41 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -2785.05 | |||||
Net Margin % | -2741.43 | |||||
FCF Margin % | -2721.87 | |||||
ROE % | -167.18 | |||||
ROA % | -66.88 | |||||
ROIC % | -139.61 | |||||
3-Year ROIIC % | -83.44 | |||||
ROC (Joel Greenblatt) % | -145.21 | |||||
ROCE % | -72.5 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 110.6 | |||||
PB Ratio | 7.61 | |||||
Price-to-Tangible-Book | 7.82 | |||||
EV-to-EBIT | -4.18 | |||||
EV-to-Forward-EBIT | -5.85 | |||||
EV-to-EBITDA | -4.33 | |||||
EV-to-Forward-EBITDA | -6.52 | |||||
EV-to-Revenue | 111.96 | |||||
EV-to-Forward-Revenue | 15.15 | |||||
EV-to-FCF | -4.13 | |||||
Price-to-Median-PS-Value | 3.02 | |||||
Earnings Yield (Greenblatt) % | -23.92 | |||||
FCF Yield % | -21.17 |